These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Low-density lipoprotein apheresis is effective in reducing lipoprotein(a) levels and in improving symptoms in a patient with refractory angina secondary to accelerated coronary artery disease. Ibrahim M; Ussen B; Pottle A; Barbir M J Clin Lipidol; 2012; 6(2):192-4. PubMed ID: 22385553 [TBL] [Abstract][Full Text] [Related]
25. Composition and immunoreactivity of serum low density lipoproteins (LDL) before and after LDL-apheresis on dextran sulfate-cellulose columns. Gandjini H; Gambert P; Athias A; Mousson C; Rifle G; Lallemant C Transfus Sci; 1994 Sep; 15(3):289-97. PubMed ID: 10155547 [TBL] [Abstract][Full Text] [Related]
26. Treatment of hyperlipidemia with a modified low density lipoprotein apheresis system with dextran sulfate. Zhao YH; Zou YG; Sun QJ; Xi D; Xing CY Ther Apher Dial; 2007 Aug; 11(4):249-54. PubMed ID: 17661829 [TBL] [Abstract][Full Text] [Related]
27. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis. Kojima S; Ogi M; Yoshitomi Y; Kuramochi M; Ikeda J; Naganawa M; Hatakeyama H Int J Artif Organs; 1997 Mar; 20(3):178-83. PubMed ID: 9151155 [TBL] [Abstract][Full Text] [Related]
28. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis. Bosch T Transfus Apher Sci; 2004 Oct; 31(2):83-8. PubMed ID: 15501411 [TBL] [Abstract][Full Text] [Related]
32. Is lipoprotein (a)-apheresis useful? Bambauer R Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926 [TBL] [Abstract][Full Text] [Related]
33. One year experience with a low density lipoprotein apheresis system. Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228 [TBL] [Abstract][Full Text] [Related]
34. Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis. Kojima S; Harada-Shiba M; Toyota Y; Kimura G; Tsushima M; Kuramochi M; Sakata T; Uchida K; Yamamoto A; Omae T Int J Artif Organs; 1992 Mar; 15(3):185-90. PubMed ID: 1521904 [TBL] [Abstract][Full Text] [Related]
35. Unmasking hypotension by beta lactam during dextran sulfate low-density lipoprotein apheresis. Takenaka T; Sakamoto M; Suzuki H Am J Kidney Dis; 2004 Dec; 44(6):e107-8. PubMed ID: 15558512 [TBL] [Abstract][Full Text] [Related]
36. Low-density lipoprotein apheresis using the Liposorber system: features of the system and clinical benefits. Yamamoto T; Yamashita T Ther Apher; 1998 Feb; 2(1):25-30. PubMed ID: 10227785 [TBL] [Abstract][Full Text] [Related]
37. Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual care. Stefanutti C; Vivenzio A; Di Giacomo S; Mazzarella B; Ferraro PM; Abbolito S Transfus Apher Sci; 2010 Feb; 42(1):21-6. PubMed ID: 19932057 [TBL] [Abstract][Full Text] [Related]
38. Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column. Kojima S; Harada-Shiba M; Nomura S; Kimura G; Tsushima M; Kuramochi M; Yamamoto A; Omae T ASAIO Trans; 1991; 37(4):644-8. PubMed ID: 1768503 [TBL] [Abstract][Full Text] [Related]
39. Removal of low-density lipoprotein from plasma by adsorption increases bradykinin and plasma nitric oxide levels in patients with peripheral atherosclerosis. Murashima J; Ueki Y; Matsunaga Y; Yano M; Matsumoto K; Miyake S; Tominaga Y; Eguchi K; Yano K Blood Coagul Fibrinolysis; 1998 Nov; 9(8):725-32. PubMed ID: 9890715 [TBL] [Abstract][Full Text] [Related]